- Home
- BAFN vs GUTS Comparison
BAFN vs GUTS Comparison
Compare BAFN & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAFN
- GUTS
- Stock Information
- Founded
- BAFN 1999
- GUTS 2010
- Country
- BAFN United States
- GUTS United States
- Employees
- BAFN N/A
- GUTS N/A
- Industry
- BAFN Savings Institutions
- GUTS
- Sector
- BAFN Finance
- GUTS
- Exchange
- BAFN Nasdaq
- GUTS NYSE
- Market Cap
- BAFN 70.2M
- GUTS 75.0M
- IPO Year
- BAFN N/A
- GUTS 2024
- Fundamental
- Price
- BAFN $17.89
- GUTS $1.21
- Analyst Decision
- BAFN
- GUTS Buy
- Analyst Count
- BAFN 0
- GUTS 1
- Target Price
- BAFN N/A
- GUTS $10.00
- AVG Volume (30 Days)
- BAFN 7.7K
- GUTS 216.7K
- Earning Date
- BAFN 04-24-2025
- GUTS 03-03-2025
- Dividend Yield
- BAFN 1.86%
- GUTS N/A
- EPS Growth
- BAFN 134.19
- GUTS N/A
- EPS
- BAFN 2.62
- GUTS N/A
- Revenue
- BAFN $83,769,000.00
- GUTS $93,000.00
- Revenue This Year
- BAFN N/A
- GUTS N/A
- Revenue Next Year
- BAFN N/A
- GUTS N/A
- P/E Ratio
- BAFN $6.53
- GUTS N/A
- Revenue Growth
- BAFN 10.60
- GUTS N/A
- 52 Week Low
- BAFN $10.40
- GUTS $1.16
- 52 Week High
- BAFN $19.21
- GUTS $8.37
- Technical
- Relative Strength Index (RSI)
- BAFN 54.31
- GUTS 32.27
- Support Level
- BAFN $17.17
- GUTS $1.27
- Resistance Level
- BAFN $18.39
- GUTS $1.46
- Average True Range (ATR)
- BAFN 0.75
- GUTS 0.14
- MACD
- BAFN -0.25
- GUTS -0.01
- Stochastic Oscillator
- BAFN 37.93
- GUTS 8.84
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a one bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.